Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Metastasis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT06686342
What this trial is testing

PDO Based Drug Sensitive Test in R/M HNSCC

Who this might be right for
Head and Neck Squamous Cell CarcinomaPatient Derived OrganoidDrug Sensitive Test in Vitro
Huashan Hospital 100
Testing effectiveness (Phase 2)Study completedNCT00309842
What this trial is testing

Myeloablative Umbilical Cord Blood Transplantation in Hematological Diseases

Who this might be right for
Acute Myeloid LeukemiaAcute Lymphocytic LeukemiaChronic Myelogenous Leukemia+10 more
Masonic Cancer Center, University of Minnesota 213
Not applicableUnknownNCT03988686
What this trial is testing

Testing Radical Prostatectomy in Chinese Men With Prostate Cancer and oligoMetastases to the Bone

Who this might be right for
Prostate Cancer Metastatic
Fudan University 120
Testing effectiveness (Phase 2)Study completedNCT02178670
What this trial is testing

Safety and Effectivity Immunotherapy to Treat Ovarian Cancer With Cancer Stem Cells Vaccine

Who this might be right for
Neoplasms,Ovarian
Fuda Cancer Hospital, Guangzhou 40
Early research (Phase 1)Study completedNCT00033241
What this trial is testing

Erlotinib Combined With Gemcitabine in Treating Patients With Newly Diagnosed Locally Advanced or Metastatic Pancreatic Cancer or Other Solid Tumors

Who this might be right for
Pancreatic CancerUnspecified Adult Solid Tumor, Protocol Specific
OSI Pharmaceuticals
Early research (Phase 1)Ended earlyNCT03580694
What this trial is testing

Study of REGN4659 in Combination With Cemiplimab in Patients With Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Regeneron Pharmaceuticals 17
Testing effectiveness (Phase 2)Looking for participantsNCT07235566
What this trial is testing

MRG003 and Pucotenlimab to Treat Locally Advanced or Metastatic ATC/PDTC

Who this might be right for
Thyroid Cancer
Fudan University 60
Testing effectiveness (Phase 2)Looking for participantsNCT06732856
What this trial is testing

A Phase Ib/II Trial of Neoadjuvant Zolbetuximab Plus Docetaxel, Oxaliplatin and S-1 Chemotherapy in Patients With Locally Advanced Gastric Cancer

Who this might be right for
Stomach NeoplasmGastric (Stomach) Cancer
Asan Medical Center 57
Testing effectiveness (Phase 2)Study completedNCT00662129
What this trial is testing

Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Gemcitabine, and Bevacizumab in Treating Patients With Metastatic Breast Cancer

Who this might be right for
Breast Cancer
Alliance for Clinical Trials in Oncology 50
Testing effectiveness (Phase 2)UnknownNCT02276937
What this trial is testing

Randomized Phase IIb Trial of DVC1-0101

Who this might be right for
Intermittent ClaudicationPeripheral Arterial Disease
Kyushu University 30
Large-scale testing (Phase 3)UnknownNCT00715637
What this trial is testing

Phase III Randomized Study of Amonafide (AS1413) and Cytarabine Versus Daunorubicin and Cytarabine in Patients With Secondary Acute Myeloid Leukemia (AML)- the ACCEDE Study

Who this might be right for
Secondary Acute Myeloid Leukemia (Secondary AML, sAML)
Antisoma Research 420
Large-scale testing (Phase 3)Study completedNCT01057537
What this trial is testing

UMPIRE - Use of a Multidrug Pill In Reducing Cardiovascular Events

Who this might be right for
Cardiovascular Diseases
Imperial College London 2,004
Not applicableUnknownNCT05637645
What this trial is testing

Different Approaches of Spinal Anesthesia in Patients Undergoing Cesarean Section

Who this might be right for
Post-Dural Puncture HeadacheHypotensionSpinal Shock+4 more
Bahawal Victoria Hospital Bahawalpur 200
Not applicableStudy completedNCT01861977
What this trial is testing

Healthy Habits Program for High Cardiovascular Risk Patients: Randomized Controlled Clinical Trial

Who this might be right for
Health BehaviorMotor ActivityFood Habits
Hospital Italiano de Buenos Aires 101
Testing effectiveness (Phase 2)Looking for participantsNCT07284277
What this trial is testing

TTFields and Chemotherapy in Metastatic Pancreatic Adenocarcinoma (mPDAC)

Who this might be right for
Pancreatic Adenocarcinoma MetastaticPancreatic Ductal Adenocarcinoma
Clinica Universidad de Navarra, Universidad de Navarra 30
Not applicableStudy completedNCT05446077
What this trial is testing

Quantitatively Analysis of Fundus Structure Characteristics in Glaucoma Following Congenital Cataract Surgery

Who this might be right for
Glaucoma SecondaryCongenital Cataract
Sun Yat-sen University 129
Large-scale testing (Phase 3)Looking for participantsNCT05956639
What this trial is testing

Comparing a 6-month vs Long-term Course of Rezvilutamide With ADT Plus Chemotherapy in mHSPC

Who this might be right for
Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)
The First Affiliated Hospital with Nanjing Medical University 100
Testing effectiveness (Phase 2)Study completedNCT01755195
What this trial is testing

Cabozantinib for Adults With Advanced Soft Tissue Sarcoma

Who this might be right for
Refractory Soft Tissue Sarcomas
National Cancer Institute (NCI) 55
Not applicableStudy completedNCT01920139
What this trial is testing

Ultrasound Guided Core Biopsy vs Fine Needle Aspiration for Evaluation of Axillary Lymphadenopathy

Who this might be right for
Focus: Breast Cancer With Axillary Node Metastasis
University of Pittsburgh 105
Not applicableStudy completedNCT02940639
What this trial is testing

Real-Life Effectiveness and Safety in Participants With Advanced/Metastatic Renal Cell Carcinoma Starting 1st Line Nivolumab and Ipilimumab Combination Therapy or Nivolumab Monotherapy After Prior Therapy

Who this might be right for
Renal Cell Carcinoma
Bristol-Myers Squibb 499
Next Page